ALDX
Price
$4.85
Change
-$0.01 (-0.21%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
FOLD
Price
$9.81
Change
+$0.08 (+0.82%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
Ad is loading...

ALDX vs FOLD

Header iconALDX vs FOLD Comparison
Open Charts ALDX vs FOLDBanner chart's image
Aldeyra Therapeutics
Price$4.85
Change-$0.01 (-0.21%)
Volume$20.05K
CapitalizationN/A
Amicus Therapeutics
Price$9.81
Change+$0.08 (+0.82%)
Volume$50.75K
CapitalizationN/A
ALDX vs FOLD Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. FOLD commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and FOLD is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ALDX: $4.88 vs. FOLD: $9.80)
Brand notoriety: ALDX and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 90% vs. FOLD: 146%
Market capitalization -- ALDX: $289.41M vs. FOLD: $2.93B
ALDX [@Biotechnology] is valued at $289.41M. FOLD’s [@Biotechnology] market capitalization is $2.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while FOLD’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • FOLD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FOLD is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -0.41% price change this week, while FOLD (@Biotechnology) price change was +4.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

FOLD is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.93B) has a higher market cap than ALDX($289M). ALDX YTD gains are higher at: 39.031 vs. FOLD (-30.937). FOLD has higher annual earnings (EBITDA): -9.2M vs. ALDX (-42.57M). FOLD has more cash in the bank: 250M vs. ALDX (113M). ALDX has less debt than FOLD: ALDX (15.6M) vs FOLD (445M). FOLD has higher revenues than ALDX: FOLD (494M) vs ALDX (0).
ALDXFOLDALDX / FOLD
Capitalization289M2.93B10%
EBITDA-42.57M-9.2M463%
Gain YTD39.031-30.937-126%
P/E RatioN/AN/A-
Revenue0494M-
Total Cash113M250M45%
Total Debt15.6M445M4%
FUNDAMENTALS RATINGS
ALDX vs FOLD: Fundamental Ratings
ALDX
FOLD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4460
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for FOLD (75). This means that ALDX’s stock grew somewhat faster than FOLD’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that ALDX’s stock grew similarly to FOLD’s over the last 12 months.

ALDX's SMR Rating (97) in the Biotechnology industry is in the same range as FOLD (98). This means that ALDX’s stock grew similarly to FOLD’s over the last 12 months.

ALDX's Price Growth Rating (44) in the Biotechnology industry is in the same range as FOLD (60). This means that ALDX’s stock grew similarly to FOLD’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that ALDX’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXFOLD
RSI
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVGSX22.590.30
+1.35%
VY® Invesco Growth and Income S
MUESX33.140.38
+1.16%
MFS Blended Research Core Equity R2
WMGCX17.500.19
+1.10%
Delaware Ivy Mid Cap Growth C
AFOCX26.390.27
+1.03%
Archer Focus
RGORX20.900.08
+0.38%
RBC Global Opportunities R6

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+0.41%
CANF - ALDX
46%
Loosely correlated
+2.78%
FOLD - ALDX
46%
Loosely correlated
+0.72%
BBIO - ALDX
42%
Loosely correlated
+1.07%
THRD - ALDX
42%
Loosely correlated
-0.37%
ATAI - ALDX
42%
Loosely correlated
N/A
More

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+0.72%
ALDX - FOLD
46%
Loosely correlated
+0.41%
VCYT - FOLD
43%
Loosely correlated
+4.66%
RCKT - FOLD
42%
Loosely correlated
+1.85%
SRPT - FOLD
42%
Loosely correlated
-0.42%
DNLI - FOLD
41%
Loosely correlated
-0.19%
More